18.04.2023 One third of all depressive disorders are chronic. According to estimates, 1.2 million people in Germany currently live with chronic depression. Often, those affected have already received

28.04.2023 Acute myeloid leukemia (AML) is a malignant disease in which the precursor cells of the hematopoietic system proliferate uncontrollably. This form of blood cancer is caused by genetic chang

Financial Risk Management Unit (FRMU) The FRMU provides support with business issues relating to economic projects with a volume > 50,000 € according to the MHH third-party funding guideline. Consulti

01.06.2022 TACTiC – Tailored Application for individualized Cell Therapy with iPSC-derived Cardiomyocytes Preclinical evaluation in a non-human primate model and a roadmap for clinical application The

17.04.2023 New cases of bile duct cancer, also known as biliary tumours, are increasing worldwide. The chances of cure are considered poor. The standard therapy for advanced bile duct cancer has so fa

03.04.2023 Hannover Medical School (MHH) has cracked the 100 million euro mark in third-party funding spent for the first time in its 58-year history. In 2022, researchers used a total of 101.4 millio

Dr. Hristo Georgiev Institute of Immunology, OE 5240 I11-02-1120 Phone: +49 511 532 9729 E-Mail: Georgiev.Hristo @ mh-hannover.de Research Focus The basic research interest of our group includes the d

20.03.2023 Pulmonary arterial hypertension (PAH) is a special form of pulmonary hypertension. It occurs because the small arteries in the lungs narrow as a result of progressive changes in the blood v

16.03.2023 In Germany, 270,000 people suffer a stroke every year. This can result in severe disabilities: Paralysis, speech disorders and problems walking. Often, it does not remain a one-time event.

Chief of the Department Prof. Dr. med. Kai Schmidt-Ott Curriculum Vitae Prof. Dr. med. Kai Schmidt-Ott Prof. Dr. Kai Schmidt-Ott is Chief of the Department of Nephrology and Hypertension at Hannover M